Home / Health / Decades Lost to Misdiagnosis: Narcolepsy's Toll
Decades Lost to Misdiagnosis: Narcolepsy's Toll
9 Oct
Summary
- Narcolepsy nearly drove a mother to suicide after decades of misdiagnosis.
- Hallucinations and cataplexy were dismissed as childish or hormonal.
- A new drug offers hope, but insurance battles and potential future treatments loom.
Amy Clifton's life was profoundly impacted by undiagnosed narcolepsy type 1 for nearly three decades. Her symptoms, starting in childhood, included insomnia, daytime sleepiness, and terrifying hallucinations, often dismissed by doctors as sleep terrors or hormonal issues.
As an adult, her condition worsened, leading to cataplexy – sudden muscle weakness triggered by strong emotions. Despite experiencing suicidal thoughts and hospitalizations, specialists misdiagnosed her with bipolar disorder, exacerbating her distress.
Her husband, Peter, chronicled her struggles, including a terrifying honeymoon incident where Amy, experiencing hallucinations and paralysis, punched him. This event, like others, underscored the severity of her undiagnosed condition.
In 2023, at age 30, Amy finally received a correct diagnosis of narcolepsy type 1. This breakthrough offered validation but not immediate access to treatment due to insurance hurdles for a crucial medication.
Amy is now cautiously hopeful with a new drug, experiencing improved energy and a significant reduction in hallucinations. She actively advocates for faster diagnosis and better treatment access for others with narcolepsy.
